Jacob Haaber Christensen

机构：Odense University Hospital

发表论文 143 篇 · 总被引 3099 次 · h-index 20

代表论文

• Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma (2025 · Blood · 被引 10)
• Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up (2025 · Blood Cancer Journal · 被引 5)
• Epcoritamab monotherapy for Richter transformation (EPCORE CLL-1): findings from a single-arm, multicentre, open-label, phase 1b/2 trial (2025 · The Lancet Haematology · 被引 4)
• Real-world outcomes with ibrutinib in relapsed or refractory mantle cell lymphoma: a Danish population-based study (2025 · Blood Neoplasia · 被引 4)
• 240 | EPCORITAMAB MONOTHERAPY DEMONSTRATES DEEP AND DURABLE RESPONSES AT 3‐YEAR FOLLOW‐UP IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (2025 · Hematological Oncology · 被引 3)
• Association of PET4 response with outcomes of BV-CHP vs CHOP in the ECHELON-2 trial in CD30+ peripheral T-cell lymphoma (2025 · Blood Advances · 被引 2)